Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
SNW:FRA
Sanofi SA
78,49 €
0,00%
(0,00) 1D
4 მაი, 20:16:14 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SNW...
Mkt. cap
95,00 მლრდ.
Avg. vol.
1,64 ათ.
Volume
0,00
P/E ratio
12,69
52-wk high
98,40 €
52-wk low
75,06 €
EPS
6,18 €
Shares outstanding
1,25 მლრდ.
No. of employees
75 ათ.
News stories
From sources across the web
Let's Data Science
Let's Data Science
·
9 საათის წინ
Sanofi expands Toronto AI centre with investment
TradingKey
TradingKey
·
13 საათის წინ
Sanofi SA Stock (SNY) Moved Down by 5.57% on May 4: What Investors Need To Know
Idéal Investisseur
Idéal Investisseur
·
16 საათის წინ
Sanofi Shares Fall 2% Following Morgan Stanley Downgrade
TipRanks
TipRanks
·
19 საათის წინ
Sanofi Stock Slips as Traders Brace for Quiet Years
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOპოლ ჰადსონ
Employees74,8 ათ.
Founded1973
Headquartersპარიზი, ილ-დე-ფრანსი, საფრანგეთი
SectorPharmaceutical industry
Websitesanofi.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
10,74 მლრდ.
13,17 მლრდ.
12,20 მლრდ.
11,24 მლრდ.
Cost of goods sold
2,99 მლრდ.
3,41 მლრდ.
3,63 მლრდ.
3,06 მლრდ.
Cost of revenue
2,99 მლრდ.
3,41 მლრდ.
3,63 მლრდ.
3,06 მლრდ.
Research and development expenses
1,91 მლრდ.
1,83 მლრდ.
2,29 მლრდ.
1,75 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,32 მლრდ.
2,29 მლრდ.
2,82 მლრდ.
2,33 მლრდ.
Operating expense
6,03 მლრდ.
5,97 მლრდ.
6,84 მლრდ.
5,94 მლრდ.
Total operating expenses
9,02 მლრდ.
9,39 მლრდ.
10,46 მლრდ.
9,00 მლრდ.
Operating income
1,71 მლრდ.
3,78 მლრდ.
1,74 მლრდ.
2,25 მლრდ.
Other non operating income
-24,00 მლნ.
-
122,00 მლნ.
-40,00 მლნ.
EBT including unusual items
1,47 მლრდ.
3,51 მლრდ.
-1,16 მლრდ.
2,01 მლრდ.
EBT excluding unusual items
1,74 მლრდ.
3,67 მლრდ.
1,70 მლრდ.
2,14 მლრდ.
Income tax expense
230,00 მლნ.
680,00 მლნ.
-348,00 მლნ.
420,00 მლნ.
Effective tax rate
15,68%
19,38%
30,13%
20,85%
Other operating expenses
1,42 მლრდ.
1,39 მლრდ.
1,19 მლრდ.
1,33 მლრდ.
Net income
3,94 მლრდ.
2,80 მლრდ.
-801,00 მლნ.
1,61 მლრდ.
Net profit margin
36,70%
21,28%
-6,56%
14,35%
Earnings per share
-
-
1,53
1,88
Interest and investment income
72,00 მლნ.
114,00 მლნ.
79,00 მლნ.
60,00 მლნ.
Interest expense
-62,00 მლნ.
-227,00 მლნ.
-
-138,00 მლნ.
Net interest expenses
10,00 მლნ.
-113,00 მლნ.
79,00 მლნ.
-78,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,48 მლრდ.
4,20 მლრდ.
3,49 მლრდ.
2,78 მლრდ.
Gain or loss from assets sale
-266,00 მლნ.
266,00 მლნ.
-79,00 მლნ.
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer